pentoxifylline has been researched along with Metabolic Syndrome in 3 studies
Metabolic Syndrome: A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components of metabolic syndrome include ABDOMINAL OBESITY; atherogenic DYSLIPIDEMIA; HYPERTENSION; HYPERGLYCEMIA; INSULIN RESISTANCE; a proinflammatory state; and a prothrombotic (THROMBOSIS) state.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pentoxifylline directly alleviated hypertension in metabolic syndrome rats, at least in part, via amelioration of low-grade inflammation and inhibition of angiotensin system." | 7.81 | Pentoxifylline alleviates hypertension in metabolic syndrome: effect on low-grade inflammation and angiotensin system. ( Azhar, A; El-Bassossy, HM, 2015) |
| "Pentoxifylline directly alleviated hypertension in metabolic syndrome rats, at least in part, via amelioration of low-grade inflammation and inhibition of angiotensin system." | 3.81 | Pentoxifylline alleviates hypertension in metabolic syndrome: effect on low-grade inflammation and angiotensin system. ( Azhar, A; El-Bassossy, HM, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azhar, A | 1 |
| El-Bassossy, HM | 1 |
| Metwally, AH | 1 |
| Pei, H | 1 |
| Gu, J | 1 |
| Thimmalapura, PR | 1 |
| Mison, A | 1 |
| Nadler, JL | 1 |
3 other studies available for pentoxifylline and Metabolic Syndrome
| Article | Year |
|---|---|
Pentoxifylline alleviates hypertension in metabolic syndrome: effect on low-grade inflammation and angiotensin system.
Topics: Angiotensin II; Animals; Disease Models, Animal; Hypertension; Inflammation; Male; Metabolic Syndrom | 2015 |
Pentoxifylline in the management of metabolic syndrome and chronic hepatitis C.
Topics: Antiviral Agents; Cardiovascular Diseases; Hepatitis C, Chronic; Humans; Insulin Resistance; Liver C | 2014 |
Activation of the 12-lipoxygenase and signal transducer and activator of transcription pathway during neointima formation in a model of the metabolic syndrome.
Topics: Angioplasty, Balloon; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonate 12-Lipoxygenase | 2006 |